KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Depreciation and Depletion (2018 - 2025)

Exact Sciences (EXAS) has disclosed Depreciation and Depletion for 13 consecutive years, with $31.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation and Depletion rose 4.62% to $31.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $121.9 million, a 0.37% change, with the full-year FY2024 number at $119.7 million, up 4.59% from a year prior.
  • Depreciation and Depletion was $31.7 million for Q3 2025 at Exact Sciences, up from $31.1 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $31.7 million in Q3 2025 to a low of $20.5 million in Q1 2021.
  • A 5-year average of $27.0 million and a median of $27.5 million in 2023 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: grew 28.12% in 2021, then decreased 5.66% in 2024.
  • Exact Sciences' Depreciation and Depletion stood at $21.0 million in 2021, then rose by 26.68% to $26.6 million in 2022, then increased by 15.96% to $30.8 million in 2023, then fell by 5.66% to $29.1 million in 2024, then increased by 8.93% to $31.7 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Depreciation and Depletion are $31.7 million (Q3 2025), $31.1 million (Q2 2025), and $30.0 million (Q1 2025).